SCHEMBL21165618

SCHEMBL21165618

c1ccc(-c2ccc(-c3ccccc3)c(-n3c4ccccc4c4ccccc43)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
APAF1 O14727 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39
PTBP1 P26599 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
GALK1 P51570 1/20 0.39
BLM P54132 1/20 0.39
SMAD3 P84022 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28242816 0.93 L3MBTL1 (0.47) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL27012178 0.92 CYP1A2 (0.47) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL20865082 0.91 ATM (0.46) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL15502538 0.91 L3MBTL1 (0.55) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL24307538 0.91 L3MBTL1 (0.42) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL24306725 0.91 L3MBTL1 (0.42) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL24065408 0.91 L3MBTL1 (0.50) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL15502615 0.91 L3MBTL1 (0.55) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL24902347 0.91 L3MBTL1 (0.42) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL15502577 0.91 L3MBTL1 (0.50) ATML3MBTL1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 ATM 1310/4885L3MBTL1 2041/4885KDM4E 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.